Bioavailability and effects of food on the pharmacokinetics of ENMD-2076 in healthy subjects

Trial Profile

Bioavailability and effects of food on the pharmacokinetics of ENMD-2076 in healthy subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 30 Jul 2013

At a glance

  • Drugs ENMD 2076 (Primary)
  • Indications Acute myeloid leukaemia; Breast cancer; Multiple myeloma; Ovarian cancer; Soft tissue sarcoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Jul 2013 New trial record
    • 29 Jul 2013 This trial has been initiated, according to an EntreMed media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top